ArticleClinical reviews in allergy & immunology2020

JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren's Syndrome.

Amandine Charras et al.PubMed ↗Publisher ↗

No numbers read from the abstract.